Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandprotesen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   11.7% 9.5% 7.7% 6.2% 4.9% 8.7% 15.8% 15.5%   Credit score (0-100)   22 27 32 37 44 27 12 13   Credit rating   BB BB BB BBB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   290 293 527 622 529 479 0.0 0.0   EBITDA   16.0 20.0 251 159 66.0 14.5 0.0 0.0   EBIT   -52.0 -48.0 183 159 66.0 14.5 0.0 0.0   Pre-tax profit (PTP)   -60.0 -56.0 176.0 148.0 56.0 9.4 0.0 0.0   Net earnings   -49.0 -44.0 137.0 110.0 40.0 2.5 0.0 0.0   Pre-tax profit without non-rec. items   -60.0 -56.0 176 148 56.0 9.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   135 68.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   15.0 -29.0 108 217 257 259 209 209   Interest-bearing liabilities   120 144 149 155 161 107 0.0 0.0   Balance sheet total (assets)   181 176 392 490 483 460 209 209   Net Debt   103 85.0 -205 -256 -131 -309 -209 -209     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   290 293 527 622 529 479 0.0 0.0   Gross profit growth   -21.2% 1.0% 79.9% 18.0% -15.0% -9.5% -100.0% 0.0%   Employees   1 0 1 1 1 1 0 0   Employee growth %   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   181 176 392 490 483 460 209 209   Balance sheet change%   -41.2% -2.8% 122.7% 25.0% -1.4% -4.7% -54.6% 0.0%   Added value   16.0 20.0 251.0 159.0 66.0 14.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -137 -135 -136 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -17.9% -16.4% 34.7% 25.6% 12.5% 3.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -21.3% -24.9% 61.3% 36.1% 13.6% 3.3% 0.0% 0.0%   ROI %   -26.9% -34.4% 91.3% 50.6% 16.7% 4.0% 0.0% 0.0%   ROE %   -124.1% -46.1% 96.5% 67.7% 16.9% 1.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   8.3% -15.3% 27.6% 44.3% 53.2% 58.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   643.8% 425.0% -81.7% -161.0% -198.5% -2,136.6% 0.0% 0.0%   Gearing %   800.0% -496.6% 138.0% 71.4% 62.6% 41.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.3% 6.1% 4.8% 7.2% 6.3% 4.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.6 1.4 1.8 2.1 2.5 0.0 0.0   Current Ratio   0.3 0.5 1.4 1.8 2.1 2.3 0.0 0.0   Cash and cash equivalent   17.0 59.0 354.0 411.0 292.0 416.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -120.0 -97.0 108.0 217.0 257.0 259.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   16 0 251 159 66 14 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   16 0 251 159 66 14 0 0   EBIT / employee   -52 0 183 159 66 14 0 0   Net earnings / employee   -49 0 137 110 40 3 0 0